Oramed Pharmaceuticals Statistics
NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.57-0.12 (-3.25%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Oramed Pharmaceuticals by the numbers
Oramed Pharmaceuticals has a market capitalization of $155.2 million based on 43.49M shares outstanding. Its trailing P/E ratio is 1.0. The stock trades 16.1% below its 50-day average and 12.2% below its 200-day average.
Average daily trading volume is 173.38K shares, or about $618,974 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ORMP valuation vs. peer median
| Metric | ORMP | Peer median | Difference |
|---|---|---|---|
| Market cap | $155.24M | $149.81M | +4% |
| Avg. volume | 173.38K | 712.60K | -76% |
Peer median across 8 companies: IFRX, ELDN, RNA, EMIS, VRXA, PRQR, BBOT, ABEO.
Valuation
- Market cap
- $155.24M
- P/E (TTM)
- 1.05
- Price / sales (latest FY)
- 77.62
- EPS (TTM)
- $3.41
- Shares outstanding
- 43.49M
Price and trading
- Previous close
- 3.69
- Open
- 3.67
- Day range
- 3.54 – 3.71
- 52-week range
- 2.52 – 5.47
- 52-week change
- +38.37%
- Beta
- —
- Volume
- 285.67K
- Average volume
- 173.38K
Dividends and events
- Annual dividend
- None
- Dividend yield
- 7.00%
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 155.24M
- Pe
- 1.05
- Forward Pe
- -44.63
- Eps
- 3.41
- Dividend Yield
- 7.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.47
- Week52 Low
- 2.52
- Avg Volume
- 173.38K
- Shares Outstanding
- 43.49M
- Ma50
- 4.25
- Ma200
- 4.07
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -34.73%
- Pct From52w Low
- 41.67%